Loading...
Market
What will be the market share of the Virchow2G model in the AI pathology tools market by December 31, 2024?
2
Resolution / Starting Odds
0-10% • 25%
11-20% • 25%
21-30% • 25%
31%+ • 25%
Market research reports from firms like Gartner, IDC, etc.
Story
Microsoft and Paige Launch Virchow2G AI Models for Cancer Diagnosis, Scaling to 1.85 Billion Parameters
Aug 15, 2024, 01:31 PM
Microsoft and Paige have collaborated to develop Virchow2 and Virchow2G, second-generation foundation models for computational pathology. These models are designed to enhance cancer diagnosis by leveraging AI and self-supervised learning techniques. The Virchow2G model significantly increases the scale of previous work, reaching 1.85 billion parameters. A paper published in Nature Medicine highlights the original Virchow model, trained on 1.5 million whole-slide images from 10,000 patients, which has improved the detection of rare cancers. This advancement represents a strategic pivot for Paige, aiming to further the role of AI in cancer care. Virchow2 and 2G are now available on Hugging Face.
View original story
Similar markets
Less than 10% • 33%
10% to 25% • 33%
More than 25% • 33%
0-10% • 25%
11-25% • 25%
26-50% • 25%
51%+ • 25%
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
Market share increases • 25%
Market share remains the same • 25%
Market share decreases • 25%
Foresight exits cancer-detection market • 25%
Mayo Clinic • 25%
Cleveland Clinic • 25%
Johns Hopkins Hospital • 25%
Other • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Less than 10% • 25%
10% - 20% • 25%
20% - 30% • 25%
More than 30% • 25%
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
0-5% • 25%
5-10% • 25%
10-15% • 25%
15% or more • 25%
Google Health • 25%
IBM Watson Health • 25%
GE Healthcare • 25%
Philips Healthcare • 25%
Less than 10 • 25%
10 to 20 • 25%
21 to 50 • 25%
More than 50 • 25%
Increase by more than 5% • 25%
Increase by 2-5% • 25%
Increase by less than 2% • 25%
No significant increase • 25%